➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Mallinckrodt
Moodys
Baxter
Medtronic

Last Updated: July 27, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DYSPORT

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for DYSPORT

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00134810 ↗ Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome Completed Ipsen Phase 2 2005-03-01 The main purpose of this study is to determine which is the best dose of a drug known as Dysport to give when treating one's type of upper back pain. The study will also examine the side effects of this treatment and its overall effect on one's disorder.
NCT00149240 ↗ Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment in Patients With Primary Myofascial Pain Syndrome Completed Ipsen Phase 2 2005-01-01 The main purpose of this study is to determine the effectiveness and safety of one dose of botulinum toxin type A (Dysport) associated with rehabilitation treatment on pain control in patients with a type of back pain called primary myofascial pain syndrome.
NCT00210444 ↗ Efficacy Study of Dysport® in the Treatment of Anal Fissure. Completed Ipsen Phase 2 2003-06-01 To evaluate the effect on healing rates of two different prognostic factors in patients treated with Dysport® for anal fissure: duration of fissure and dose of study drug
NCT00213577 ↗ NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder Terminated University Hospital, Rouen Phase 2 2003-12-01 The purpose of this study is to determine the efficacy and tolerance of 2 dosages (750 versus 500 units) of the Dysport type A botulinic toxin for patient suffering from neurogenic urinary incontinence by an overactive bladder and the failure of anticholinergic drugs.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for DYSPORT

Condition Name

Condition Name for DYSPORT
Intervention Trials
Cervical Dystonia 9
Overactive Bladder 5
Cerebral Palsy 5
Muscle Spasticity 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for DYSPORT
Intervention Trials
Muscle Spasticity 12
Dystonic Disorders 10
Dystonia 10
Torticollis 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for DYSPORT

Trials by Country

Trials by Country for DYSPORT
Location Trials
United States 193
France 14
Czech Republic 12
Poland 12
Germany 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for DYSPORT
Location Trials
California 15
New York 14
Florida 14
Texas 14
Pennsylvania 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for DYSPORT

Clinical Trial Phase

Clinical Trial Phase for DYSPORT
Clinical Trial Phase Trials
Phase 4 24
Phase 3 25
Phase 2/Phase 3 4
[disabled in preview] 20
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for DYSPORT
Clinical Trial Phase Trials
Completed 46
Not yet recruiting 16
Recruiting 10
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DYSPORT

Sponsor Name

Sponsor Name for DYSPORT
Sponsor Trials
Ipsen 44
Brazilan Center for Studies in Dermatology 4
Rajavithi Hospital 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for DYSPORT
Sponsor Trials
Industry 54
Other 46
U.S. Fed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Johnson and Johnson
AstraZeneca
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.